Hanson & Doremus Investment Management Dr Reddys Laboratories LTD Transaction History

Hanson & Doremus Investment Management

$748 Million
Q2 2025

A detailed history of Hanson & Doremus Investment Management transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 15,161 shares of RDY stock, worth $210,889. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,161

Previous 15,856 4.38%

Holding current value

$210,889

Previous $209,000 9.09%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$12.36 - $16.17 $8,590 - $11,238	-695 Reduced 4.38%	15,161 $228,000
Q1 2025 Apr 17, 2025	SELL	$12.53 - $15.81 $91,644 - $115,634	-7,314 Reduced 31.57%	15,856 $209,000
Q4 2024 Jan 23, 2025	BUY	$13.99 - $79.75 $259,318 - $1.48 Million	18,536 Added 400.0%	23,170 $365,000
Q2 2024 Aug 08, 2024	SELL	$68.26 - $76.19 $12,628 - $14,095	-185 Reduced 3.84%	4,634 $353,000
Q1 2024 Apr 22, 2024	SELL	$67.36 - $77.59 $35,364 - $40,734	-525 Reduced 9.82%	4,819 $353,000
Q4 2023 Jan 25, 2024	SELL	$64.27 - $69.9 $7,198 - $7,828	-112 Reduced 2.05%	5,344 $371,000
Q3 2023 Oct 24, 2023	SELL	$61.9 - $72.77 $29,650 - $34,856	-479 Reduced 8.07%	5,456 $364,000
Q3 2022 Oct 20, 2022	SELL	$49.9 - $57.32 $21,756 - $24,991	-436 Reduced 6.84%	5,935 $311,000
Q4 2021 Jan 20, 2022	SELL	$59.5 - $67.25 $10,710 - $12,105	-180 Reduced 2.75%	6,371 $417,000
Q3 2021 Oct 21, 2021	SELL	$60.19 - $75.29 $42,373 - $53,004	-704 Reduced 9.7%	6,551 $426,000
Q2 2021 Jul 22, 2021	BUY	$62.12 - $74.2 $7,143 - $8,533	115 Added 1.61%	7,255 $505,000
Q1 2021 May 03, 2021	SELL	$57.98 - $73.08 $4,058 - $5,115	-70 Reduced 0.97%	7,140 $438,000
Q4 2020 Feb 01, 2021	SELL	$62.61 - $71.29 $2,817 - $3,208	-45 Reduced 0.62%	7,210 $514,000
Q3 2020 Oct 19, 2020	SELL	$51.39 - $72.41 $159,617 - $224,905	-3,106 Reduced 29.98%	7,255 $505,000
Q2 2020 Jul 17, 2020	SELL	$39.55 - $54.65 $30,255 - $41,807	-765 Reduced 6.88%	10,361 $549,000
Q1 2020 Apr 24, 2020	SELL	$34.75 - $45.85 $57,372 - $75,698	-1,651 Reduced 12.92%	11,126 $448,000
Q4 2019 Jan 16, 2020	SELL	$36.66 - $41.78 $5,645 - $6,434	-154 Reduced 1.19%	12,777 $518,000
Q2 2019 Jul 18, 2019	SELL	$36.05 - $42.76 $2,739 - $3,249	-76 Reduced 0.58%	12,931 $485,000
Q2 2018 Aug 08, 2018	SELL	$28.49 - $35.06 $18,803 - $23,139	-660 Reduced 4.83%	13,007 $419,000
Q1 2018 May 10, 2018	BUY	$31.93 - $39.54 $21,073 - $26,096	660 Added 5.07%	13,667 $447,000
Q4 2017 Jan 25, 2018	SELL	$34.15 - $37.62 $5,464 - $6,019	-160 Reduced 1.22%	13,007 $489,000
Q3 2017 Oct 26, 2017	BUY	$30.11 - $37.72 $396,458 - $496,659	13,167	13,167 $0

Others Institutions Holding RDY

# of Institutions

261

Shares Held

102M

Call Options Held

12.5K

Put Options Held

800

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Dr Reddys Laboratories LTD Transaction History